• Title/Summary/Keyword: Cardiotoxicity

Search Result 84, Processing Time 0.026 seconds

A Case of Gemcitabine Plus Nanoparticle Albumin Bound (nab)-paclitaxel Induced Cardiotoxicity in Patient of Metastatic Pancreatic Cancer (전이성 췌장암 환자에서 Gemcitabine과 Nanoparticle Albumin Bound (nab)-Paclitaxel로 인한 허혈성 심독성 발생 1례)

  • Mi Kang Kim;Se Woo Park
    • Journal of Digestive Cancer Research
    • /
    • v.5 no.1
    • /
    • pp.62-65
    • /
    • 2017
  • Pancreatic cancer is an aggressive disease and despite the efforts of the past few decades, the 5-year overall survival (OS) rate remains disappointing and does not exceed 10% in Korea. Especially, only 15-20% of patients are candidates for surgical resection because most patients are diagnosed with locally advanced or metastatic disease, and their only treatment approach is palliative chemotherapy. Since the first chemo-regimen of Gemcitabine and Nanoparticle albumin bound (nab) - paclitaxel was brought to clinical practice in 2013, the improvement in overall survival, progression-free survival, and response rate was achieved in patients with metastatic pancreatic adenocarcinoma. We report the case of a young patient with cardiogenic shock accompanied by multi-organ failure after 4th cycle Gemcitabine and nab-paclitaxel chemotherapy with partial response.

  • PDF

A Fatal Case of Colchicine Poisoning (콜히친(Colchicine) 음독 후 사망한 환자 1례)

  • Ko, Seung Hyun;Lee, Gun Woo
    • Journal of The Korean Society of Clinical Toxicology
    • /
    • v.15 no.1
    • /
    • pp.51-55
    • /
    • 2017
  • Colchicine is a drug that has long been used to treat a variety of illnesses; however, it reportedly has adverse effects at apparent toxic doses as well as at lower and therapeutically recommended doses. The typical therapeutic dose of colchicine is up to 2.4 mg daily, although it is sometimes as high as 8-10 mg daily. Here, we describe a case in which the patient showed sudden deterioration and died because of unintentional colchicine poisoning with a relatively small dose. When a colchicine poisoned patient visits the hospital, the physician should identify the patient's colchicine poisoning dose and concomitant drugs. Moreover, the patients should be monitored intensively for 24 to 72 hours and managed with various supportive treatment methods early and actively.

Selectivity of the optical isomers of KR30031 on MDR reversal activity and cardiotoxicity

  • Lee, Byung-Ho;Lee, Chong-Ock;Kwon, Myung-Ja;Yi, Kyu-Yang;Yoo, Sung-Eun;Choi, Sang-Un
    • Proceedings of the PSK Conference
    • /
    • 2002.10a
    • /
    • pp.251.3-252
    • /
    • 2002
  • The present study was performed to compare the cardiovascular adverse effects of verapamil. KR30031 and their each optical isomers, and also to measure their ability to overcome multidrug resistance (MDR). R-isomer of KR30031 (R-KR30031) was equipotent with S-isomer of KR30031 (S-KR30031) and 25 fold less potent than R-isomer of verapamil (R-verapamil) in relaxing the aorta isolated from rat (EC50: 11.8, 10.2 and 0.46 ${\mu}$M, respectively). (omitted)

  • PDF

Effect of L-Carnitine on the Cardioxicity Induced by Doxorubicin (Doxorubicin유발 심장독성에 미치는 L-Carnitine의 효과)

  • Kim, Hyoung-Chun;Song, Ke-Yong;Jeon, Ku-Seok;Huh, In-Hoi
    • YAKHAK HOEJI
    • /
    • v.32 no.4
    • /
    • pp.230-233
    • /
    • 1988
  • This study was undertaken to elucidate the role of L-carnitine on cardiotoxicity induced by doxorubicin in mice. We designed to investigate both lipoperoxidation and histopathology in experimental group. The results obtained from prior with concurrent treatment of L-carnitine showed as follows; 1) Combination of L-carnitine showed significant inhibition of lipoperoxide in liver than heart. 2) By means of electron microscopy, we obtained histological evidence that doxorubicin-induced cardiomyopathy, is prevented by L-carnitine.

  • PDF

A Case of Aconite Poisoning Successfully Recovered after Intravenous Fat Emulsion Therapy (정맥 내 지질 유탁액 치료 후 성공적으로 회복한 초오 중독 1례)

  • Shin, Hee Jun;Lim, Hoon
    • Journal of The Korean Society of Clinical Toxicology
    • /
    • v.14 no.1
    • /
    • pp.60-65
    • /
    • 2016
  • Aconitum is a genus of various species of flowering plants that belongs to the Family Ranunculaceae. Most Aconitum sp. have extremely toxic alkaloid substances such as aconitine, mesaconitine and hypaconitine. Among these substances, aconitine can cause fatal cardiotoxicity by activating sodium channels followed by calcium channels in myocardial cells. Even though there have been various therapeutic plans suggested comprising antidotes based on diverse case reports and studies, there is no confirmatory treatment protocol for aconite poisoning. Here, we report an aconite poisoning patient who had refractory ventricular tachyarrhythmia that did not respond to intravenous amiodarone therapies even though they were sustained for over 2 hours, but showed successful recovery following intravenous fat emulsions (IFE) therapy.

  • PDF

Effects of Myrrha Water Extract on Rat Myocardial Cells in Cultures (몰약 전탕액이 배양 심근세포에 미치는 영향)

  • 권강범;조현익;김구환;김상범;이호섭;황우준;박승택;류도곤
    • The Journal of Korean Medicine
    • /
    • v.21 no.2
    • /
    • pp.79-86
    • /
    • 2000
  • Objectives and Methods : In order to elucidate toxic mechanism of myocardial damage and protective effect of myrrha water extract against cytotoxic effect of xanthine oxidase/hypoxanthine(XO/HX), cardioprotective effect of myrrha water extract was examined by MTT assay, LDH (Lactate Dehydrogenase) activity and heart beating rate after cultured myocardial cells derived from neonatal mouse were treated with various concentration of XO/HX, a free radical. Results : XO/HX induced a decrease of cell viability, an increase in the amount of LDH, and a decrease of heart beating rate on cultured myocardial cells in a dose-dependent manner. In cardioprotective effect of myrrha water extract, it showed a decrease in the amount of LDH and an increase of heart beating rate on cultured myocardial cells damaged by XO/HX. Conclusions : From the above results, it is suggested that XO/HX showed toxic effect in cultured myocardial cells derived from neonatal mouse and that myrrha water extract is very effective in the prevention of XO/HX-induced cardiotoxicity.

  • PDF

Synthesis of Benzoquinoxalines

  • Kwon, Nam-Koong;Lee, Hee-Soon
    • Proceedings of the PSK Conference
    • /
    • 2002.10a
    • /
    • pp.351.2-351.2
    • /
    • 2002
  • We have previously reported the synthesis and cytotoxic activities of a series of azaanthraquinone derivatives on the model of doxorubicin(Dox). Dox is known to intercalate into DNA and to inhibit topoisomerase II activity. But in the case of Quinone compounds like Dox. its use is limited because of systemic toxicities. primarily cardiotoxicity and myelosuppression. In this study. we describe the synthesis of benzoquinoxaline derivatives as DACA analogue. DACA has a neutral chromophore and acridine moiety and posions both topoisomerases I and ll with DNA intercalating activity. In order to delineate the SAR of benzoquinoxaline derivatives. an effcient sythetic rout to the target compounds without quinone group. Various attempted removal of quinone from benzoquinoxlinedione was unsuccessful. Diels-Alder rout applied for the synthesis of the target compounds will be discussed.

  • PDF

Drug-drug interaction with DA-125 and the other anticancer drugs

  • Park, Kyung-Jin;Yoon, Hea-Sun;Jang, Ji-Myun;Shim, Hyun-Joo;Kim, Soon-Hoe;Kim, Won-Bae
    • Proceedings of the PSK Conference
    • /
    • 2003.04a
    • /
    • pp.313.1-313.1
    • /
    • 2003
  • DA-125, a novel anthracycline analog containing fluorine with decreased cardiotoxicity and increased antitumor activity of adriamycin (ADM), developed by Research Laboratories of Dong-A Pharmaceutical. DA-125, water soluble prodrug of M1, is a ${\beta}$-alanine derivative of M1 (FT-ADM). DA-125 was rapidly hydrolyzed to M1, and M1 was metabolized to both M2 and M3. (omitted)

  • PDF

Design and Synthesis of N-Aryl 8,9-Dihydro-7H-isoindolo[5,6-g]quinoxaline-7,9-dione Derivatives as Potential Antitumor Agent

  • Lee, Hee-Soon;Jung, Eun-Kyung;Nam, Koong-Kwon;Jung, Jae-Kyung
    • Proceedings of the PSK Conference
    • /
    • 2003.10b
    • /
    • pp.174.1-174.1
    • /
    • 2003
  • We have previously reported the synthesis and cytotoxic activities of a series of azaanthraquinone derivatives using doxorubicin as a lead compound. Doxorubicin is known to intercalate into DNA and to inhibit topoisomerase II activity. But in the case of quinone compounds like Dox, its use is limited because of systemic toxicities, primarily cardiotoxicity and myelosuppression. In this study, we discuss the synthesis of isoindolobenzoquinoxaline derivatives. The quinone group of the azaanthraquinone derivatives were removed in the target compounds. (omitted)

  • PDF

Screening for the 3' UTR Polymorphism of the PXR Gene in South Indian Breast Cancer Patients and its Potential role in Pharmacogenomics

  • Revathidevi, Sundaramoorthy;Sudesh, Ravi;Vaishnavi, Varadharajan;Kaliyanasundaram, Muthukrishnan;MaryHelen, Kilyara George;Sukanya, Ganesan;Munirajan, Arasambattu Kannan
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.17 no.8
    • /
    • pp.3971-3977
    • /
    • 2016
  • Background: Breast cancer, the commonest cancer among women in the world, ranks top in India with an incidence rate of 1,45,000 new cases and mortality rate of 70,000 women every year. Chemotherapy outcome for breast cancer is hampered due to poor response and irreversible dose-dependent cardiotoxicity which is determined by genetic variations in drug metabolizing enzymes and transporters. Pregnane X receptor (PXR), a member of the nuclear receptor superfamily, induces expression of drug metabolizing enzymes (DMEs) and transporters leading to regulation of xenobiotic metabolism. Materials and Methods: A genomic region spanning PXR 3' UTR was amplified and sequenced using genomic DNA isolated from 96 South Indian breast cancer patients. Genetic variants observed in our study subjects were queried in miRSNP to establish SNPs that alter miRNA binding sites in PXR 3' UTR. In addition, enrichment analysis was carried out to understand the network of miRNAs and PXR in drug metabolism using DIANA miRpath and miRwalk pathway prediction tools. Results: In this study, we identified SNPs rs3732359, rs3732360, rs1054190, rs1054191 and rs6438550 in the PXR 3; UTR region. The SNPs rs3732360, rs1054190 and rs1054191 were located in the binding site of miR-500a-3p, miR-532-3p and miR-374a-3p resulting in the altered PXR level due to the deregulation of post-transcriptional control and this leads to poor treatment response and toxicity. Conclusions: Genetic variants identified in PXR 3' UTR and their effects on PXR levels through post-transcriptional regulation provide a genetic basis for interindividual variability in treatment response and toxicity associated with chemotherapy.